This report examines the accessibility of the Yellow Card Scheme, a critical system for monitoring the safety of medicines in the UK. The review was commissioned to assess how effectively healthcare professionals and the public can report suspected adverse drug reactions. It investigates the processes, communication channels, and user experience associated with the scheme, aiming to identify barriers and propose improvements to ensure comprehensive and timely reporting.

This report is a formal governmental review focused on the operational aspects of the Yellow Card Scheme. Its reception would likely be within regulatory bodies, public health organizations, and among professionals involved in drug safety monitoring. The document's purpose is to provide actionable insights for improving a key public health system.